Jci_page_head_homepage_01 Jci_page_head_homepage_02
Rosa Marina Melillo, Maria Domenica Castellone, Valentina Guarino, Valentina De Falco, Anna Maria Cirafici, Giuliana Salvatore, Fiorina Caiazzo, Fulvio Basolo, Riccardo Giannini, Mogens Kruhoffer, Torben Orntoft, Alfredo Fusco, Massimo Santoro
Published in Volume 115, Issue 4
J Clin Invest. 2005; 115(4):1068–1081 doi:10.1172/JCI22758
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 2

Generation of thyroid cell cultures. (A) Protein lysates (50 μg) extracted from the indicated cell lines underwent Western blotting with anti-RET, -tag (myc), or -RAS antibodies. Equal protein loading was ascertained by anti-tubulin immunoblot. (B) Mass populations of PC cells transfected with the indicated plasmids were photographed using a phase-contrast light microscope (magnification, ×150). RET/PTC3-, RET/PTC3(Y1015F)-, BRAF(V600E)-, and HRAS(V12)-expressing cells displayed a transformed morphology, whereas RET/PTC3(Y1062F)-expressing cells were virtually indistinguishable from parental cells. (C) Protein extracts from the indicated cell lines were subjected to immunoblotting with anti–phospho-p44/42 ERK antibodies. The blot was reprobed with anti-p44/42 antibodies for normalization. (D) BRAF targeting by siRNA but not by scrambled siRNA induced BRAF downregulation and ERK inhibition, as shown by Western blotting with specific antibodies.